“This is the first major study to compare the effect of two common diabetes treatments — GLP-1 medicines and metformin — on dementia risk, using health records from more than 174,000 people. The ...

Much has been written about the incredible story of the science and the parallel story of bringing the law, regulations and public on this journey and it’s an impressive tale. What I want to focus on ...

Dr Maxime Taquet, Associate Professor in the Department of Psychiatry, University of Oxford, said: ...